Salicylic acid

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the removal of warts, including plantar warts, flat warts, common warts, as well as corns and calluses. Plantar warts are specifically characterized by their location on the bottom of the foot, tenderness upon pressure, and disruption of the normal footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly prior to treatment. It is recommended to soak the wart in warm water for approximately 5 minutes to facilitate the process. After soaking, the area must be dried thoroughly.

Using an applicator, such as a cotton swab, a layer of ointment should be applied to sufficiently cover each wart. It is important to allow the ointment to fully absorb into the skin. If necessary, the treated area may be covered with a bandage to protect it.

This procedure should be repeated once or twice daily as needed, continuing until the wart is removed, for a maximum duration of 12 weeks.

Contraindications

Use of this product is contraindicated in the following situations:

• Application on damaged skin, including cuts, abrasions, eczema, or sunburn, is prohibited due to the risk of exacerbating the condition and causing further irritation.

• Individuals with known allergies to any of the ingredients in this product should not use it, as this may lead to severe allergic reactions.

• The product is contraindicated in pregnant or breastfeeding individuals due to potential risks to the fetus or infant.

Warnings and Precautions

The liquid formulation is prone to volatilization and crystallization; therefore, it is imperative to securely tighten the cap after each use to maintain its integrity. Prolonged exposure to air should be avoided to ensure optimal efficacy.

This product is intended for external use only. It must not come into contact with the eyes or be ingested. Children should utilize this product only under the supervision of an adult to prevent accidental misuse.

Caution is advised when applying this product. It should not be used on damaged skin, including areas with cuts, abrasions, eczema, or sunburn. Additionally, individuals with known allergies to any of the ingredients in this formulation should refrain from use. Pregnant or breastfeeding individuals should also avoid using this product unless directed by a healthcare professional.

In the event of adverse reactions or if there is a suspicion of a more serious skin condition, it is essential to discontinue use and consult a healthcare provider for further evaluation and management.

Side Effects

Patients using this product should be aware of several important safety considerations. The liquid formulation is prone to volatilization and crystallization; therefore, it is essential to tighten the cap securely after each use to maintain its integrity. Long-term exposure to air should be avoided to prevent degradation of the product.

This product is intended for external use only. Patients must take care to avoid contact with the eyes and should not ingest the product. It is recommended that children use this product under the supervision of an adult to ensure safe application.

In the event of any adverse reactions or if there are concerns regarding a more serious skin condition, patients are advised to consult a healthcare professional for further evaluation and guidance.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Tag Wart Remover. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should use this medication under the supervision of adults. Caregivers are advised to monitor the administration and effects closely to ensure safety and efficacy in this population.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should be advised to consult their healthcare provider regarding the use of this medication. The potential risks and benefits must be carefully considered in these populations. There is limited data available on the effects of this medication during pregnancy and lactation, and its safety has not been established. Therefore, healthcare professionals should exercise caution and evaluate the necessity of treatment in pregnant or breastfeeding women, taking into account the potential impact on fetal outcomes and infant health.

Lactation

Lactating mothers should be aware of the potential implications of using this medication while breastfeeding. There is limited information available regarding the excretion of this drug in human breast milk. Therefore, healthcare professionals should carefully consider the benefits and risks of administering this medication to lactating mothers.

Breastfed infants may be affected by the presence of the drug in breast milk, although specific data on the effects in nursing infants are not provided. It is advisable for healthcare providers to monitor breastfed infants for any adverse effects if the mother is using this medication.

In cases where the medication is deemed necessary, healthcare professionals should counsel lactating mothers on the importance of adhering to prescribed dosages and report any unusual symptoms in their infants promptly.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there is no information available regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary depending on the substance involved and the individual patient’s characteristics. Symptoms of overdose can range from mild to severe and may include altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate medical evaluation is recommended. Healthcare professionals should assess the patient's vital signs and conduct a thorough clinical examination. Supportive care should be initiated as necessary, including airway management, oxygen supplementation, and intravenous fluids.

If specific antidotes or treatments are available for the substance involved, they should be administered according to established protocols. Continuous monitoring of the patient’s condition is crucial, and appropriate laboratory tests may be warranted to guide further management.

In all cases of suspected overdose, it is advisable to contact a poison control center or a medical toxicologist for expert guidance on management strategies tailored to the specific situation.

Nonclinical Toxicology

If you are pregnant or breastfeeding, there may be teratogenic effects associated with the use of this product. No non-teratogenic effects have been reported in the available data. Additionally, there is no further information provided regarding nonclinical toxicology or animal pharmacology and toxicology.

Postmarketing Experience

No specific postmarketing experience details are available in the extracted data. As such, there are no additional adverse events or rare case reports to summarize.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children to prevent accidental ingestion or misuse.

Patients should be instructed not to use the product on damaged skin, including areas with cuts, abrasions, eczema, or sunburn, as this may exacerbate irritation or lead to adverse effects.

It is important for healthcare providers to inquire about any known allergies to the ingredients in the product. Patients should be informed to discontinue use and consult their healthcare provider if they experience any allergic reactions.

Additionally, healthcare providers should discuss the implications of using the product during pregnancy or while breastfeeding. Patients should be encouraged to inform their healthcare provider if they are pregnant or breastfeeding before using the product.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available upon request. It is essential to store the product at a temperature range of 68°F to 77°F (20°C to 25°C). Care should be taken to protect the product from excessive heat, specifically temperatures exceeding 104°F (40°C). Proper storage conditions are crucial to maintain the integrity and efficacy of the product.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Tag Wart Remover, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)